"Tu1572 Effectiveness and Safety of Multi-Modality Endoscopic Eradication Therapy for Dysplastic Barrett's Esophagus and Early Esophageal Cancer: Results From an International, Multi-Center Consortium" by Stefan Seewald

Selected Works of Sravanthi Parasa, MPH, MD

Article

Tu1572 Effectiveness and Safety of Multi-Modality Endoscopic Eradication Therapy for Dysplastic Barrett's Esophagus and Early Esophageal Cancer: Results From an International, Multi-Center Consortium

Gastrointestinal Endoscopy (2015)

Stefan Seewald, Eppendorf (Germany)
Vani J. Konda, University of Chicago
Prashanth Vennalaganti, United States Department of Veterans Affairs
Neil Gupta, Loyola University Medical Center
Alessandro Repici, Humanitas University
Sharad C. Mathur, United States Department of Veterans Affairs
Mojtaba S. Olyaee, University of Kansas
Daniel C. Buckles, University of Kansas
Sumalatha Muthineni, University of Kansas
Jesica Brown, University of Kansas
Sravanthi Parasa, University of Kansas
Ajay Bansal, United States Department of Veterans Affairs
Prateek Sharma, United States Department of Veterans Affairs

Link

Disciplines

Publication Date

January 5, 2015

DOI

10.1016/j.gie.2015.03.1760

Citation Information

Stefan Seewald, Vani J. Konda, Prashanth Vennalaganti, Neil Gupta, et al.. "Tu1572 Effectiveness and Safety of Multi-Modality Endoscopic Eradication Therapy for Dysplastic Barrett's Esophagus and Early Esophageal Cancer: Results From an International, Multi-Center Consortium" Gastrointestinal Endoscopy Vol. 81 Iss. 5 (2015)
Available at: http://works.bepress.com/sravanthi-parasa/24/